Yan Liu1, Hongen Chen1, Di Mu1, Di Li1, Yuan Zhong1, Nan Jiang1, Yuan Zhang1, Min Xia2. 1. From the Guangdong Provincial Key Laboratory of Food, Nutrition, and Health, Guangzhou, Guangdong Province, China (Y.L., H.C., D.M., D.L., Y.Z., N.J., M.X.); Department of Nutrition, School of Public Health, Sun Yat-sen University (Northern Campus), Guangzhou, Guangdong Province, China (Y.L., H.C., D.M., D.L., Y.Z., N.J., M.X.); and Department of Cardiology, General Hospital of Guangzhou Military Command of People's Liberation Army, Guangdong, China (Y.Z.). 2. From the Guangdong Provincial Key Laboratory of Food, Nutrition, and Health, Guangzhou, Guangdong Province, China (Y.L., H.C., D.M., D.L., Y.Z., N.J., M.X.); Department of Nutrition, School of Public Health, Sun Yat-sen University (Northern Campus), Guangzhou, Guangdong Province, China (Y.L., H.C., D.M., D.L., Y.Z., N.J., M.X.); and Department of Cardiology, General Hospital of Guangzhou Military Command of People's Liberation Army, Guangdong, China (Y.Z.). xiamin@mail.sysu.edu.cn.
Abstract
RATIONALE: Retinoic acid (RA) and its mediated nuclear receptor signaling have broad protective effects on vascular systems. Whether circulating levels of RA are associated with mortality in patients with coronary artery disease is still unknown. OBJECTIVE: To evaluate the association of circulating RA with the risk of mortality. METHODS AND RESULTS: We measured serum RA concentrations in 1499 patients with angiographically confirmed coronary artery disease (mean age, 61 years; male, 67%) recruited from October 2008 and December 2011 in the Guangdong Coronary Artery Disease Cohort. During a median (interquartile range) period of 4.4 (3.6 to 6.1) years of follow-up, there were 295 all-cause mortality, among which 208 had cardiovascular mortality. Serum RA level was significantly lower in participants with mortality (median 21 [11-47] nmol/L) than in those without mortality (median 39 [19-86] nmol/L). In multivariate analyses, the hazard ratios for total mortality among those in the lowest (referent) to highest quartiles of serum RA measured at study entry were 1.0, 0.83, 0.74, and 0.56, respectively (P-trend<0.001). For cardiovascular mortality, the comparable hazard ratios were 1.0, 0.76, 0.69, and 0.60 (P-trend<0.001). Furthermore, high RA levels (defined as >median) were associated with lower risk of total mortality (adjusted hazard ratios, 0.68; 95% confidence interval, 0.50-0.85; P=0.001) and cardiovascular mortality (adjusted hazard ratios, 0.62; 95% confidence interval, 0.45-0.78; P<0.001) compared with low RA (defined as ≤median). CONCLUSIONS: Serum RA level was associated with lower risk of mortality in a population-based coronary artery disease cohort.
RATIONALE: Retinoic acid (RA) and its mediated nuclear receptor signaling have broad protective effects on vascular systems. Whether circulating levels of RA are associated with mortality in patients with coronary artery disease is still unknown. OBJECTIVE: To evaluate the association of circulating RA with the risk of mortality. METHODS AND RESULTS: We measured serum RA concentrations in 1499 patients with angiographically confirmed coronary artery disease (mean age, 61 years; male, 67%) recruited from October 2008 and December 2011 in the Guangdong Coronary Artery Disease Cohort. During a median (interquartile range) period of 4.4 (3.6 to 6.1) years of follow-up, there were 295 all-cause mortality, among which 208 had cardiovascular mortality. Serum RA level was significantly lower in participants with mortality (median 21 [11-47] nmol/L) than in those without mortality (median 39 [19-86] nmol/L). In multivariate analyses, the hazard ratios for total mortality among those in the lowest (referent) to highest quartiles of serum RA measured at study entry were 1.0, 0.83, 0.74, and 0.56, respectively (P-trend<0.001). For cardiovascular mortality, the comparable hazard ratios were 1.0, 0.76, 0.69, and 0.60 (P-trend<0.001). Furthermore, high RA levels (defined as >median) were associated with lower risk of total mortality (adjusted hazard ratios, 0.68; 95% confidence interval, 0.50-0.85; P=0.001) and cardiovascular mortality (adjusted hazard ratios, 0.62; 95% confidence interval, 0.45-0.78; P<0.001) compared with low RA (defined as ≤median). CONCLUSIONS: Serum RA level was associated with lower risk of mortality in a population-based coronary artery disease cohort.
Authors: Jaume Amengual; Johana Coronel; Courtney Marques; Celia Aradillas-García; Juan Manuel Vargas Morales; Flavia C D Andrade; John W Erdman; Margarita Teran-Garcia Journal: J Nutr Date: 2020-08-01 Impact factor: 4.798
Authors: Stephanie Zalesak-Kravec; Weiliang Huang; Pengcheng Wang; Jianshi Yu; Tian Liu; Amy E Defnet; Alexander R Moise; Ann M Farese; Thomas J MacVittie; Maureen A Kane Journal: Health Phys Date: 2021-10-01 Impact factor: 2.922
Authors: Stephanie Zalesak-Kravec; Weiliang Huang; Jace W Jones; Jianshi Yu; Jenna Alloush; Amy E Defnet; Alexander R Moise; Maureen A Kane Journal: FASEB J Date: 2022-04 Impact factor: 5.834
Authors: Oyunbileg Magvanjav; Yan Gong; Caitrin W McDonough; Arlene B Chapman; Stephen T Turner; John G Gums; Kent R Bailey; Eric Boerwinkle; Amber L Beitelshees; Toshihiro Tanaka; Michiaki Kubo; Carl J Pepine; Rhonda M Cooper-DeHoff; Julie A Johnson Journal: J Am Heart Assoc Date: 2017-11-02 Impact factor: 5.501